Can Psychedelics Be Used To Treat Traumatic Brain Injury? This Company Thinks So

April 22, 2022 11:59 AM | 24 seconds read |

Daniel Carcillo, CEO and Founder of Wesana Health Holdings WSNAF, was a guest speaker at Benzinga’s Psychedelic Capital Conference on April 19, 2022. 

Wesana is a life science company pioneering developments in psychedelic treatments for mental health care. 

Watch the full interview here. 

Photo by Raimond Klavins on Unsplash

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Health CareGeneralBenzinga Psychedelics Capital ConferencePartner ContentWesana Health Holdings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!